- Home
- KOS vs LENZ Comparison
KOS vs LENZ Comparison
Compare KOS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOS
- LENZ
- Stock Information
- Founded
- KOS 2003
- LENZ 2019
- Country
- KOS United States
- LENZ United States
- Employees
- KOS N/A
- LENZ N/A
- Industry
- KOS Oil & Gas Production
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- KOS Energy
- LENZ Health Care
- Exchange
- KOS Nasdaq
- LENZ Nasdaq
- Market Cap
- KOS 822.2M
- LENZ 886.0M
- IPO Year
- KOS 2011
- LENZ 2021
- Fundamental
- Price
- KOS $2.21
- LENZ $31.62
- Analyst Decision
- KOS Buy
- LENZ Strong Buy
- Analyst Count
- KOS 6
- LENZ 5
- Target Price
- KOS $4.52
- LENZ $41.80
- AVG Volume (30 Days)
- KOS 7.6M
- LENZ 312.6K
- Earning Date
- KOS 08-04-2025
- LENZ 05-07-2025
- Dividend Yield
- KOS N/A
- LENZ N/A
- EPS Growth
- KOS N/A
- LENZ N/A
- EPS
- KOS N/A
- LENZ N/A
- Revenue
- KOS $1,546,854,000.00
- LENZ N/A
- Revenue This Year
- KOS N/A
- LENZ N/A
- Revenue Next Year
- KOS $11.57
- LENZ $544.90
- P/E Ratio
- KOS N/A
- LENZ N/A
- Revenue Growth
- KOS N/A
- LENZ N/A
- 52 Week Low
- KOS $1.39
- LENZ $16.54
- 52 Week High
- KOS $5.66
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- KOS 58.91
- LENZ 47.66
- Support Level
- KOS $1.95
- LENZ $32.43
- Resistance Level
- KOS $2.35
- LENZ $34.44
- Average True Range (ATR)
- KOS 0.12
- LENZ 2.05
- MACD
- KOS 0.02
- LENZ -0.28
- Stochastic Oscillator
- KOS 69.57
- LENZ 15.10
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.